CRISPR Therapeutics
CRSP
#3365
Rank
A$5.23 B
Marketcap
$61.07
Share price
-1.74%
Change (1 day)
-43.73%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.99

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$8.41. In 2022 the company made an earnings per share (EPS) of -$13.28 a decrease over its 2021 EPS that were of $7.92.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.99-39.83%
2022-$13.28-267.74%
2021$7.92-194.33%
2020-$8.39-576.58%
2019$1.76-132.36%
2018-$5.44100.58%
2017-$2.71159.42%
2016-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.46-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA